Philadelphia Biotech Startup Context Therapeutics Names a New CFO, Effective Immediately Post author:Sam Post published:November 15, 2017 Post category:BioPharma The company is strengthening its team as it transitions to a clinical development stage company. Source: BioSpace You Might Also Like How Immigration Ban is Already Hurting Science January 29, 2017 Bay Area's Tricia Closes $57.5M Series D, Pushes Into Phase III Trial November 7, 2017 Mysterious Biotech Unicorn Moderna Nabs Another $500M, Is Now Worth $7B February 1, 2018